CWF19L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.917000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.376400E-01
Normal-vs-Stage2
4.770600E-01
Normal-vs-Stage3
3.378000E-01
Normal-vs-Stage4
4.625600E-01
Stage1-vs-Stage2
6.630800E-01
Stage1-vs-Stage3
5.078800E-01
Stage1-vs-Stage4
5.782200E-01
Stage2-vs-Stage3
5.914800E-01
Stage2-vs-Stage4
8.801200E-01
Stage3-vs-Stage4
7.990800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.074400E-01
Normal-vs-AfricanAmerican
3.559200E-01
Normal-vs-Asian
4.020200E-01
Caucasian-vs-AfricanAmerican
1.293200E-01
Caucasian-vs-Asian
1.966180E-01
AfricanAmerican-vs-Asian
5.161800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.897600E-01
Normal-vs-Female
4.929400E-01
Male-vs-Female
9.463000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.480200E-01
Normal-vs-Age(41-60Yrs)
5.288200E-01
Normal-vs-Age(61-80Yrs)
4.661400E-01
Normal-vs-Age(81-100Yrs)
5.583400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.534000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.296200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.968200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.725370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.455600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.610600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.474000E-01
Normal-vs-Daily Drinker
5.440600E-01
Normal-vs-Weekly Drinker
5.071400E-01
Normal-vs-Occasional Drinker
5.802800E-01
Normal-vs-Social Drinker
5.617800E-01
Non Drinker-vs-Daily Drinker
2.775800E-01
Non Drinker-vs-Weekly Drinker
5.192600E-01
Non Drinker-vs-Occasional Drinker
1.792000E-01
Non Drinker-vs-Social Drinker
3.033800E-01
Daily Drinker-vs-Weekly Drinker
7.042200E-01
Daily Drinker-vs-Occasional Drinker
7.330800E-01
Daily Drinker-vs-Social Drinker
9.007000E-01
Weekly Drinker-vs-Occasional Drinker
4.783000E-01
Weekly Drinker-vs-Social Drinker
6.576200E-01
Occasional Drinker-vs-Social Drinker
8.665400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.836600E-01
Normal-vs-Grade 2
7.126400E-01
Normal-vs-Grade 3
6.825000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.502400E-01
Grade 1-vs-Grade 3
8.318000E-01
Grade 1-vs-Grade 4
3.836600E-01
Grade 2-vs-Grade 3
4.627800E-01
Grade 2-vs-Grade 4
7.126400E-01
Grade 3-vs-Grade 4
6.825000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.258000E-01
Normal-vs-NonDiabetic
4.745800E-01
Diabetic-vs-NonDiabetic
3.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.122000E-01
Normal-vs-NoPancreatitis
4.754000E-01
Pancreatitis-vs-NoPancreatitis
1.582960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.448200E-01
Normal-vs-N1
4.697800E-01
N0-vs-N1
1.417820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.952600E-01
Normal-vs-TP53-NonMutant
5.284200E-01
TP53-Mutant-vs-TP53-NonMutant
6.227000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
